Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$10,996,393
+$1,073,841 QoQ
Shares Held
43,298
+6.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,056
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. JNJ ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,531 | $31,822,079 | |
| 2 | ABBV |
AbbVie Inc.
|
85,535 | $21,524,027 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
43,298 | $10,996,393 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
59,347 | $7,497,899 | |
| 5 | MRK |
Merck & Co., Inc.
|
51,784 | $6,654,244 | |
| 6 | AMGN |
Amgen Inc
|
15,621 | $5,656,676 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,475 | $1,006,909 | |
| 8 | PFE |
Pfizer Inc
|
40,733 | $980,850 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,996,393 | 43,298 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $9,922,552 | 40,593 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,349,692 | 16,186 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,972,097 | 16,029 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,385,955 | 15,620 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,468,694 | 14,886 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,228,015 | 15,406 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,521,167 | 15,557 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,566,689 | 10,719 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,815,863 | 11,479 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,527,901 | 9,748 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,347,704 | 8,653 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,664,800 | 10,058 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,485,675 | 9,585 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,811,015 | 10,252 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,747,461 | 10,697 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,857,464 | 10,464 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,675,177 | 9,452 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,455,805 | 8,510 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $929,755 | 5,757 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $886,136 | 5,379 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $825,037 | 5,020 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $858,665 | 5,456 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $789,361 | 5,302 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $750,120 | 5,334 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $680,302 | 5,188 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||